Add to ORKGGemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The U
Background: Biliary tract cancers are uncommon tumors with a poor prognosis and most patients (pts) ...
BACKGROUND: Chemotherapy is a critical treatment option in advanced biliary tract cancer (BTC), whic...
International audienceBackground:Gemcitabine/Cisplatin (Gem/CDDP) combination has demonstrated a cle...
Background: we assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients ...
BACKGROUND: We assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients ...
OBJECTIVES: The aim of this phase II study was to evaluate the response rate to gemcitabine combined...
[[abstract]]BACKGROUND & AIMS: Gemcitabine plus cisplatin (GC) remains the standard, frontline thera...
[Purpose]Gemcitabine/cisplatin combination therapy has been the standard palliative chemotherapy for...
Background: There is no established standard chemotherapy for patients with locally advanced or meta...
Objective: Patients with advanced biliary tract cancers have a dismal prognosis. The aim of this stu...
PURPOSE: Combination chemotherapy with gemcitabine and cisplatin is a standard treatment for patient...
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: ...
AbstractBackgroundOnly recently has a standard chemotherapy regimen, gemcitabine plus cisplatin, bee...
This chapter analyses the role of chemotherapy in the palliative treatment of patients with locally ...
[[abstract]]Gemcitabine plus platinum, notably cisplatin, is conceived as the standard regimen for a...
Background: Biliary tract cancers are uncommon tumors with a poor prognosis and most patients (pts) ...
BACKGROUND: Chemotherapy is a critical treatment option in advanced biliary tract cancer (BTC), whic...
International audienceBackground:Gemcitabine/Cisplatin (Gem/CDDP) combination has demonstrated a cle...
Background: we assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients ...
BACKGROUND: We assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients ...
OBJECTIVES: The aim of this phase II study was to evaluate the response rate to gemcitabine combined...
[[abstract]]BACKGROUND & AIMS: Gemcitabine plus cisplatin (GC) remains the standard, frontline thera...
[Purpose]Gemcitabine/cisplatin combination therapy has been the standard palliative chemotherapy for...
Background: There is no established standard chemotherapy for patients with locally advanced or meta...
Objective: Patients with advanced biliary tract cancers have a dismal prognosis. The aim of this stu...
PURPOSE: Combination chemotherapy with gemcitabine and cisplatin is a standard treatment for patient...
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: ...
AbstractBackgroundOnly recently has a standard chemotherapy regimen, gemcitabine plus cisplatin, bee...
This chapter analyses the role of chemotherapy in the palliative treatment of patients with locally ...
[[abstract]]Gemcitabine plus platinum, notably cisplatin, is conceived as the standard regimen for a...
Background: Biliary tract cancers are uncommon tumors with a poor prognosis and most patients (pts) ...
BACKGROUND: Chemotherapy is a critical treatment option in advanced biliary tract cancer (BTC), whic...
International audienceBackground:Gemcitabine/Cisplatin (Gem/CDDP) combination has demonstrated a cle...